BioCentury | Apr 13, 2018
Emerging Company Profile

Reversing Neuropathy

...Founded: 2016 by Acetylon Pharmaceuticals Inc. University collaborators: Icahn School of Medicine at Mount Sinai, Radboud University Medical Center...
BioCentury | Aug 25, 2016
Distillery Therapeutics

Therapeutics: Neurotrophic tyrosine kinase receptor 2 (TrkB; NTRK2)

...et al. J. Neurosci.; published online Aug. 3, 2016 doi:10.1523/JNEUROSCI.2711-14.2016 CONTACT: Michel M. M. Verheij, Radboud University Nijmegen Medical Centre...
BioCentury | May 16, 2016
Emerging Company Profile

EMT interrupted

...gradual loss of original cellular characteristics. CEO Henk Viëtor and his colleague Jack Schalken at Radboud University Nijmegen Medical Centre...
...Society, Aberdeen, U.K. International Bone and Mineral Society, Chicago, Ill. Oncodrone B.V., Nijmegen, the Netherlands Radboud University Nijmegen Medical Centre...
...Preclinical Founded: 2013 by Jack Schalken, Henk Viëtor, Radboud University Nijmegen Medical Centre , Compound Handling B.V. University collaborators: Radboud University Nijmegen Medical Centre...
BioCentury | Oct 23, 2014
Distillery Techniques

Technology: Imaging

...Lütje, S. et al. Cancer Res.; published online Sept. 24, 2014; doi:10.1158/0008-5472.CAN-14-0594 Contact: Susanne Lütje, Radboud University Nijmegen Medical Centre...
BioCentury | Aug 9, 2012
Targets & Mechanisms

Isis takes on myotonic dystrophy

...its own ASO strategy for DM1. In 2009, Thornton collaborated with Prosensa and researchers at Radboud University Nijmegen Medical Centre...
...NASDAQ:BIIB), Weston, Mass. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Prosensa B.V. , Leiden, the Netherlands Radboud University Nijmegen Medical Centre...
BioCentury | May 28, 2012
Company News

ElexoPharm, Khondrion B.V., Pharmacelsus GmbH, Radboud University Nijmegen Medical Centre pharmaceuticals news

...GmbH , Saarbruecken, Germany Khondrion B.V. , Nijmegen, the Netherlands Pharmacelsus GmbH , Saarbruecken, Germany Radboud University Nijmegen Medical Centre...
BioCentury | Nov 3, 2011
Distillery Techniques

Technology: Imaging

...Acad. Sci. USA; published online Oct. 24, 2011; doi:10.1073/pnas.1113045108 Contact: I. Jolanda M. de Vries, Radboud University Nijmegen Medical Centre...
BioCentury | Aug 18, 2011
Targets & Mechanisms

Predictive biomarkers for MS

...in Science Translational Medicine . The paper also included researchers from Walker Bioscience , the Radboud University Nijmegen Medical Centre...
...Stockholm, Sweden Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. Radboud University Nijmegen Medical Centre...
BioCentury | Jan 6, 2011
Distillery Therapeutics

Indication: Endocrine disease

...Stienstra, R. et al. Cell Metab.; published online Dec. 1, 2010; doi:10.1016/j.cmet.2010.11.011 Contact: Rinke Stienstra, Radboud University Nijmegen Medical Centre...
BioCentury | Mar 18, 2010
Distillery Therapeutics

Indication: Ophthalmic disease

...al. Am. J. Hum. Genet.; published online Feb. 12, 2010; doi:10.1016/j.ajhg.2009.12.016 Contact: Frans P.M. Cremers, Radboud University Nijmegen Medical Centre...
Items per page:
1 - 10 of 13
BioCentury | Apr 13, 2018
Emerging Company Profile

Reversing Neuropathy

...Founded: 2016 by Acetylon Pharmaceuticals Inc. University collaborators: Icahn School of Medicine at Mount Sinai, Radboud University Medical Center...
BioCentury | Aug 25, 2016
Distillery Therapeutics

Therapeutics: Neurotrophic tyrosine kinase receptor 2 (TrkB; NTRK2)

...et al. J. Neurosci.; published online Aug. 3, 2016 doi:10.1523/JNEUROSCI.2711-14.2016 CONTACT: Michel M. M. Verheij, Radboud University Nijmegen Medical Centre...
BioCentury | May 16, 2016
Emerging Company Profile

EMT interrupted

...gradual loss of original cellular characteristics. CEO Henk Viëtor and his colleague Jack Schalken at Radboud University Nijmegen Medical Centre...
...Society, Aberdeen, U.K. International Bone and Mineral Society, Chicago, Ill. Oncodrone B.V., Nijmegen, the Netherlands Radboud University Nijmegen Medical Centre...
...Preclinical Founded: 2013 by Jack Schalken, Henk Viëtor, Radboud University Nijmegen Medical Centre , Compound Handling B.V. University collaborators: Radboud University Nijmegen Medical Centre...
BioCentury | Oct 23, 2014
Distillery Techniques

Technology: Imaging

...Lütje, S. et al. Cancer Res.; published online Sept. 24, 2014; doi:10.1158/0008-5472.CAN-14-0594 Contact: Susanne Lütje, Radboud University Nijmegen Medical Centre...
BioCentury | Aug 9, 2012
Targets & Mechanisms

Isis takes on myotonic dystrophy

...its own ASO strategy for DM1. In 2009, Thornton collaborated with Prosensa and researchers at Radboud University Nijmegen Medical Centre...
...NASDAQ:BIIB), Weston, Mass. Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Prosensa B.V. , Leiden, the Netherlands Radboud University Nijmegen Medical Centre...
BioCentury | May 28, 2012
Company News

ElexoPharm, Khondrion B.V., Pharmacelsus GmbH, Radboud University Nijmegen Medical Centre pharmaceuticals news

...GmbH , Saarbruecken, Germany Khondrion B.V. , Nijmegen, the Netherlands Pharmacelsus GmbH , Saarbruecken, Germany Radboud University Nijmegen Medical Centre...
BioCentury | Nov 3, 2011
Distillery Techniques

Technology: Imaging

...Acad. Sci. USA; published online Oct. 24, 2011; doi:10.1073/pnas.1113045108 Contact: I. Jolanda M. de Vries, Radboud University Nijmegen Medical Centre...
BioCentury | Aug 18, 2011
Targets & Mechanisms

Predictive biomarkers for MS

...in Science Translational Medicine . The paper also included researchers from Walker Bioscience , the Radboud University Nijmegen Medical Centre...
...Stockholm, Sweden Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Pfizer Inc. (NYSE:PFE), New York, N.Y. Radboud University Nijmegen Medical Centre...
BioCentury | Jan 6, 2011
Distillery Therapeutics

Indication: Endocrine disease

...Stienstra, R. et al. Cell Metab.; published online Dec. 1, 2010; doi:10.1016/j.cmet.2010.11.011 Contact: Rinke Stienstra, Radboud University Nijmegen Medical Centre...
BioCentury | Mar 18, 2010
Distillery Therapeutics

Indication: Ophthalmic disease

...al. Am. J. Hum. Genet.; published online Feb. 12, 2010; doi:10.1016/j.ajhg.2009.12.016 Contact: Frans P.M. Cremers, Radboud University Nijmegen Medical Centre...
Items per page:
1 - 10 of 13